OptimizeRx (OPRX) Income from Non-Controlling Interests (2021 - 2023)
OptimizeRx (OPRX) posted Income from Non-Controlling Interests of -$4.2 million for Q2 2023, up 34.95% sequentially from -$6.4 million in Q1 2023, and down 7.12% YoY from -$4.5 million in Q2 2022.
OptimizeRx (OPRX) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends
OptimizeRx has reported Income from Non-Controlling Interests for 3 years, with the latest figure at -$4.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -81,000.00 |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | - |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | OptimizeRx | 164.25 Mn | 140.15 Mn | 15.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -4.16 Mn |
| Mar 31, 2023 | -6.40 Mn |
| Sep 30, 2022 | -3.47 Mn |
| Jun 30, 2022 | -3.88 Mn |
| Mar 31, 2022 | -3.76 Mn |
| Sep 30, 2021 | 39,894.00 |
| Jun 30, 2021 | 352,100.00 |